Skip to main content
  • Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

    Externally Produced and Endorsed
    Sponsor: Neurocritical Care Society
    Specialty: Trauma
    Publisher: Neurocritical Care, 2016

    read the guideline

    BACKGROUND

    The use of antithrombotic agents, including anticoagulants, antiplatelet agents, and thrombolytics has increased over the last decade and is expected to continue to rise. Although antithrombotic-associated intracranial hemorrhage can be devastating, rapid reversal of coagulopathy may help limit hematoma expansion and improve outcomes.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy